Daniel Catenacci
@doccatenacci
Medical Oncologist. "Targeted therapies for targeted populations”
ID: 2561811649
https://www.linkedin.com/in/daniel-catenacci-58779940/ 11-06-2014 17:51:29
1,1K Tweet
2,2K Takipçi
376 Takip Edilen
@mmeatock Yes research warranted, not SOC. Control here arm did very well compared to overt stage IV disease, as expected, since these are highly selected patients. This control arm is so critical because it normalizes and shows that they do well, but not due to the surgical intervention.